Lovastin Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Lovastatin

Indications/Uses

Reduction of elevated total & LDL-C in patients w/ primary hypercholesterolaemia (types IIa & IIb), when dietary & other non-pharmacological measures alone are inadequate. Reduce elevated LDL-C in patients w/ combined hypercholesterolaemia & hypertriglyceridaemia.

Click to view Lovastin detailed prescribing information

Dosage/Direction for Use

Initially 20 mg daily, adjusted at 4 wkly intervals to max: 80 mg daily.

Click to view Lovastin detailed prescribing information

Overdosage

View Lovastin overdosage for action to be taken in the event of an overdose.

Administration

Should be taken with food.

Contraindications

Active disease or unexplained persistent elevation of serum transaminases. Pregnancy & lactation.

Click to view Lovastin detailed prescribing information

Special Precautions

Perform LFTs at baseline & 4-6 wkly during 1st 15 mth of therapy. Childn.

Click to view Lovastin detailed prescribing information

Use In Pregnancy & Lactation

Click to view Lovastin detailed prescribing information

Adverse Reactions

GI discomfort, muscle cramps, myalgia, myopathy rhabdomyolysis, dizziness, headache, fatigue, sleep disorders, insomnia, rash, pruritus, blurred vision, dysgeusia, marked persistent increases of serum transminases.

Click to view Lovastin detailed prescribing information

Drug Interactions

Immunosuppressants, gemfibrozil, niacin, erythromycin, itraconazole, coumarin anticoagulants.

Click to view Lovastin detailed prescribing information

Storage

View Lovastin storage conditions for details to ensure optimal shelf-life.

Action

View Lovastin mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Dyslipidaemic Agents

ATC Classification

C10AA02 - lovastatin ; Belongs to the class of HMG CoA reductase inhibitors. Used in the treatment of hyperlipidemia.

Regulatory Classification

Presentation/Packing

Form

Lovastin tab 20 mg

Packing/Price

50 × 10's

Lovastin

lovastatin

Manufacturer:

Y.S.P. Industries

Distributor:

Y.S.P. Industries